QuantRx Biomedical has introduced new point-of-care (POC) diagnostic reader device, Q-Reader, at MEDICA 2009 in Dusseldorf, Germany. The Q-Reader addresses the performing of advanced medical diagnostic procedures where
Merck KGaA (Merck) has entered into a strategic alliance with the Deutsche Gesellschaft fur technische Zusammenarbeit (German Technical Cooperation – GTZ). It is intended to improve laboratory chemicals
Pfizer and Crown Bioscience (Crown) have entered into a collaboration to research and develop novel therapeutics for Asian cancers. Specific treatments for Asian cancers represent an important unmet
Eli Lilly (Lilly) has agreed to a one-year renewal of its drug discovery collaboration with Applied NeuroSolutions. Lilly is expected to pay $250,000 to Applied NeuroSolutions for the
Millipore has introduced Scepter, a handheld, automated cell counter, at the American Society of Cell Biology Annual Meeting in San Diego. Scepter miniaturizes Coulter cell counting technology found
Bayer’s consumer care division has begun a voluntary recall of a single product lot of the combination package of Alka-Seltzer Plus day and night cold formula liquid gels,
RTS Life Science plans to launch its Tube Auditor instrument. The Tube Auditor features vision technology (patent pending), which allows fast and accurate volume measurement of samples, and
BiondVax has completes the Phase I/II clinical trial of the Multimeric-001 Universal Flu vaccine. The trials were conducted at the Sourasky Medical Center in Tel Aviv, Israel. The
Van Andel Institute (VAI) has expanded its 240,000 square foot facility with an investment of $178m on December 8, 2009. The expanded facility creates economic and scientific opportunity
McKesson is set to introduce the PROmanager-Rx system, a solution that enables hospitals to fully automate the dispensing of tablets, capsules, and other oral solid medications that come pre-packaged from
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.